SCOPUS 정보 검색 플랫폼

Arthritis Care and Research

Volumn 61, Issue 9, 2009, Pages 1268-1270

Case of anakinra as a steroid-sparing agent for gout inflammation

(3) Gratton, Sarah B a,b Scalapino, Kenneth J b,c Fye, Kenneth H a

a UNIVERSITY OF CALIFORNIA (United States)

b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER (United States)

c UNIVERSITY OF CALIFORNIA (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; COLCHICINE; FEBUXOSTAT; PREDNISONE; PROBENECID; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TRIAMCINOLONE; URATE;

ADULT; ARTICLE; BIREFRINGENCE; CASE REPORT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG DOSE TITRATION; DRUG MEGADOSE; GOUT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERURICEMIA; KIDNEY DISEASE; KIDNEY FAILURE; LOW DRUG DOSE; MALE; MOON FACE; SIDE EFFECT; SKIN FRAGILITY; STEVENS JOHNSON SYNDROME; SYNOVITIS; TREATMENT FAILURE; URIC ACID NEPHROPATHY; WEIGHT GAIN;

ANTIRHEUMATIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; GOUT; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; MIDDLE AGED; PREDNISONE; TREATMENT OUTCOME;

EID: 69749116766 PISSN: 21514658 EISSN: None Source Type: Journal
DOI: 10.1002/art.24694 Document Type: Article

Times cited : (45)

References (6)

1
- 36849095530
- The inflammasome, autoinflammatory diseases, and gout
- Petrilli V, Martinon F. The inflammasome, autoinflammatory diseases, and gout. Joint Bone Spine 2007;74:571-576
- (2007) Joint Bone Spine , vol.74 , pp. 571-576
- Petrilli, V.¹ Martinon, F.²

2
- 34047174085
- A pilot study of IL-1 inhibition by anakinra in acute gout
- DOI 10.1186/ar2143
- So A, De Smedt T, Revaz S, Tschopp J. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 2007; 9:R28. (Pubitemid 46511126)
- (2007) Arthritis Research and Therapy , vol.9
- So, A.¹ De Smedt, T.² Revaz, S.³ Tschopp, J.⁴

3
- 25644447521
- Pathogenesis of gout
- Choi HK, Mount DB, Reginato AM. Pathogenesis of gout. Ann Intern Med 2005;143:499-516.
- (2005) Ann Intern Med , vol.143 , pp. 499-516
- Choi, H.K.¹ Mount, D.B.² Reginato, A.M.³

4
- 51849118368
- Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: Results of a phase II randomized study
- Sundy JS, Becker MA, Baraf HS, Barkhuizen A, Moreland LW, Huang W, et al. Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study. Arthritis Rheum 2008;58:2882-2891
- (2008) Arthritis Rheum , vol.58 , pp. 2882-2891
- Sundy, J.S.¹ Becker, M.A.² Baraf, H.S.³ Barkhuizen, A.⁴ Moreland, L.W.⁵ Huang, W.⁶

5
- 18644374105
- Blocking IL-1 in systemic inflammation
- Dinarello CA. Blocking IL-1 in systemic inflammation. J Exp Med 2005;201:1355-1359
- (2005) J Exp Med , vol.201 , pp. 1355-1359
- Dinarello, C.A.¹

6
- 49449094179
- Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies
- Hoffman HM, Throne ML, Amar NJ, Sebai M, Kivitz AJ, Kavanaugh A, et al. Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis Rheum 2008;58:2443-2452
- (2008) Arthritis Rheum , vol.58 , pp. 2443-2452
- Hoffman, H.M.¹ Throne, M.L.² Amar, N.J.³ Sebai, M.⁴ Kivitz, A.J.⁵ Kavanaugh, A.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.